Literature DB >> 23711932

Monogenic autoinflammatory diseases: concept and clinical manifestations.

Adriana Almeida de Jesus1, Raphaela Goldbach-Mansky.   

Abstract

The objective of this review is to describe the clinical manifestations of the growing spectrum of monogenic autoinflammatory diseases including recently described syndromes. The autoinflammatory diseases can be grouped based on clinical findings: 1. the three classic hereditary "periodic fever syndromes", familial Mediterranean Fever (FMF); TNF receptor associated periodic syndrome (TRAPS); and mevalonate kinase deficiency/hyperimmunoglobulinemia D and periodic fever syndrome (HIDS); 2. the cryopyrin associated periodic syndromes (CAPS), comprising familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and neonatal-onset multisystem inflammatory disease (NOMID) or CINCA, and; 3. pediatric granulomatous arthritis (PGA); 4. disorders presenting with skin pustules, including deficiency of interleukin 1 receptor antagonist (DIRA); Majeed syndrome; pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome; deficiency of interleukin 36 receptor antagonist (DITRA); CARD14 mediated psoriasis (CAMPS), and early-onset inflammatory bowel diseases (EO-IBD); 5. inflammatory disorders caused by mutations in proteasome components, the proteasome associated autoinflammatory syndromes (PRAAS) and 6. very rare conditions presenting with autoinflammation and immunodeficiency. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23711932      PMCID: PMC3769788          DOI: 10.1016/j.clim.2013.03.016

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  167 in total

1.  Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

Authors:  Andrew P Demidowich; Alexandra F Freeman; Douglas B Kuhns; Ivona Aksentijevich; John I Gallin; Maria L Turner; Daniel L Kastner; Steven M Holland
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.

Authors:  Ariel C Bulua; Douglas B Mogul; Ivona Aksentijevich; Harjot Singh; David Y He; Larry R Muenz; Michael M Ward; Cheryl H Yarboro; Daniel L Kastner; Richard M Siegel; Keith M Hull
Journal:  Arthritis Rheum       Date:  2012-03

3.  Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome.

Authors:  Antonio Torrelo; Sapna Patel; Isabel Colmenero; Dolores Gurbindo; Francisco Lendínez; Angela Hernández; Juan Carlos López-Robledillo; Ali Dadban; Luis Requena; Amy S Paller
Journal:  J Am Acad Dermatol       Date:  2010-03       Impact factor: 11.527

4.  Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.

Authors:  Sule Apras Bilgen; Levent Kilic; Ali Akdogan; Sedat Kiraz; Umut Kalyoncu; Omer Karadag; Ihsan Ertenli; Ismail Dogan; Meral Calguneri
Journal:  J Clin Rheumatol       Date:  2011-10       Impact factor: 3.517

5.  PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome.

Authors:  Anil K Agarwal; Chao Xing; George N DeMartino; Dario Mizrachi; Maria Dolores Hernandez; Ana Berta Sousa; Laura Martínez de Villarreal; Heloísa G dos Santos; Abhimanyu Garg
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

6.  Familial pityriasis rubra pilaris is caused by mutations in CARD14.

Authors:  Dana Fuchs-Telem; Ofer Sarig; Maurice A M van Steensel; Ofer Isakov; Shirli Israeli; Janna Nousbeck; Katharina Richard; Veronique Winnepenninckx; Marigje Vernooij; Noam Shomron; Jouni Uitto; Philip Fleckman; Gabriele Richard; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

7.  Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization.

Authors:  Merav Lidar; Jean-Michel Scherrmann; Yael Shinar; Angela Chetrit; Elisabeth Niel; Ruth Gershoni-Baruch; Pnina Langevitz; Avi Livneh
Journal:  Semin Arthritis Rheum       Date:  2004-02       Impact factor: 5.532

8.  The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.

Authors:  Ivona Aksentijevich; Christopher D Putnam; Hal M Hoffman; Daniel L Kastner; Elaine F Remmers; James L Mueller; Julie Le; Richard D Kolodner; Zachary Moak; Michael Chuang; Frances Austin; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2007-04

9.  Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.

Authors:  K A Papp; C E M Griffiths; K Gordon; M Lebwohl; P O Szapary; Y Wasfi; D Chan; M-C Hsu; V Ho; P D Ghislain; B Strober; K Reich
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

10.  First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome.

Authors:  Laura Obici; Carlo Manno; Andrea Onetti Muda; Paolo Picco; Andrea D'Osualdo; Giovanni Palladini; Maria Antonietta Avanzini; Diletta Torres; Sabrina Marciano; Giampaolo Merlini
Journal:  Arthritis Rheum       Date:  2004-09
View more
  64 in total

Review 1.  Genetically defined autoinflammatory diseases.

Authors:  A A de Jesus; R Goldbach-Mansky
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

2.  Rash, Fever, and Pulmonary Hypertension in a 6-Year-Old Female.

Authors:  David Buchbinder; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky; Hermine Brunner; Andrew I Shulman
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-04-02       Impact factor: 4.794

3.  Inflammation and wound repair.

Authors:  Danny C LeBert; Anna Huttenlocher
Journal:  Semin Immunol       Date:  2014-05-19       Impact factor: 11.130

Review 4.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 5.  Evasion of inflammasome activation by microbial pathogens.

Authors:  Tyler K Ulland; Polly J Ferguson; Fayyaz S Sutterwala
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

6.  Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia.

Authors:  Xiaolong Dong; Luyao Liu; Ying Wang; Xiaotao Yang; Wenjie Wang; Li Lin; Bijun Sun; Jia Hou; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Danru Liu; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2019-02-27       Impact factor: 8.317

7.  Autoinflammatory diseases in childhood, part 2: polygenic syndromes.

Authors:  María Navallas; Emilio J Inarejos Clemente; Estíbaliz Iglesias; Mónica Rebollo-Polo; Joan Calzada Hernández; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2020-02-17

Review 8.  Autoinflammatory diseases in childhood, part 1: monogenic syndromes.

Authors:  María Navallas; Emilio J Inarejos Clemente; Estíbaliz Iglesias; Mónica Rebollo-Polo; Faizah Mohd Zaki; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2020-02-17

9.  Lesson of the month 1: Autoinflammatory syndromes - an unusual cause of pyrexia of unknown origin.

Authors:  Ravi Varma; Gary Campbell; Helen Baxendale
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

10.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.